Skip to main content

Table 1 Variant information and selected clinical data for samples with SMARCA2 sequence variants

From: New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome

Sample ID

Variant

Inheritance

PolyPhen Prediction Effect (score)

SIFT prediction effect

Mutation Taster prediction effect

CADD score

ExAC Total frequency

Diagnosis

ACMG classification

NCBRS-SMARCA2 score

SMARCA2_1

c.3493C > A, p.Gln1165Lys

de novo

Probably damaging (0.924)

Deleterious

Disease causing

22.9

NCBRS

Pathogenic

0.37

SMARCA2_2

c.3209 T > A, p.Leu1070Gln

Probably damaging (0.998)

Deleterious

Disease causing

29.3

NCBRS

Likely pathogenic

0.27

SMARCA2_4

c.2639 C > T, p.Thr880Ile

Probably damaging (0.999)

Deleterious

Disease causing

28.2

NCBRS

VUS

0.25

SMARCA2_5

c.2648C > T, p.Pro883Leu

Probably damaging (0.999)

Deleterious

Disease causing

28.9

NCBRS

Likely pathogenic

0.24

SMARCA2_6

c.2486C > T, p.Thr829Ile

de novo

Probably damaging (0.999)

Deleterious

Disease causing

29.1

NCBRS

Pathogenic

0.22

SMARCA2_7

c.2264A > G, p.Lys755Arg

Probably damaging (0.997)

Deleterious

Disease causing

33.0

NCBRS

Pathogenic

0.36

SMARCA2_8

c.3623C > G, p.Ser1208Cys

de novo

Probably damaging (0.999)

Deleterious

Disease causing

27.0

NCBRS

Likely pathogenic

0.32

SMARCA2_9

c.2348C > G, p.Ser783Trp

de novo

Probably damaging (1.0)

Deleterious

Disease causing

34.0

NCBRS

Likely pathogenic

0.22

SMARCA2_10

c.2564G > C, p.Arg855Pro

de novo

Probably damaging (0.999)

Deleterious

Disease causing

28.7

NCBRS

VUS

0.24

SMARCA2_11

c.2255G > C, p.Gly752Ala

Probably damaging (0.999)

Deleterious

Disease causing

27.9

NCBRS

Likely pathogenic

0.27

SMARCA2_12

c.3849G > T, p.Trp1283Cys

de novo

Probably damaging (0.999)

Tolerated

Disease causing

34.0

NCBRS

VUS

−0.04

SMARCA2_14

c.2558G > T, p.Gly853Val

Probably damaging (0.83)

Deleterious

Disease causing

29.7

NCBRS

VUS

0.29

SMARCA2_15

c.400G > A, p.Val134Ile

Probably damaging (0.84)

Tolerated

Disease causing

22.3

0.00001648

VUS

−0.25

SMARCA2_16

c.674A > C, p.Gln225Pro

Benign (0)

Tolerated

Benign

14.7

0.0001821

Benign

−0.32

SMARCA2_17

c.689A > C, p.Gln230Pro

Benign (0)

Tolerated

Polymorphism

12.7

0.0003702

Benign

−0.31

SMARCA2_18

c.695A > C, p.Gln232Pro

Benign (0)

Tolerated

Polymorphism

12.7

0.0006005

Benign

−0.30

SMARCA2_19

c.1878-3 T > C, p.Gly626,

 -

 -

Benign

−0.24

  1. Cases used to generate the NCBRS-SMARCA2 DNAm signature are in bold. CADD score > 20 indicates a variant in the top 1% of deleterious variants in the human genome, > 30 in the top 0.1%. ACMG classification was made by the referring clinical laboratory for each sample. NCBRS-SMARCA2 score was generated in this study based on the DNAm signature (see Methods). Detailed clinical data are presented in Additional file 2: Table S1